Access to PrEP for MSM: Acceptability and Feasibility in Community-based Clinics in West Africa (CohMSM-PrEP)

• Status: Active, not recruiting
• Trial end date: 2021-06-30

Summary

This demonstration project will assess the acceptability and feasibility of pre-exposure prophylaxis (PrEP) for men who have sex with men (MSM) as part of a comprehensive HIV prevention package in community-based clinics in West Africa.

An interventional, open label, multidisciplinary and multicentre cohort study will be performed in Burkina Faso, Côte d'Ivoire, Mali, and Togo.

All MSM enrolled will benefit from a comprehensive HIV prevention package including quarterly clinical examinations, screening and treatment of STIs, screening of HIV, PrEP (daily or on-demand, according the participant's choice), immunisation against hepatitis B, individualised peer-led support (for adherence and prevention), group discussions, condoms, and lubricants.

• Phase: N/A

Details

• Lead Sponsor: ANRS, Emerging Infectious Diseases; French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
• Collaborators: ARCAD-SIDA MALI; ARCAD-SIDA, Bamako, Mali; Association African Solidarité; Association African Solidarité, Ouagadougou, Burkina Faso; Centre de Recherche Internationale pour la Santé, Université de Ouagadougou; Coalition Internationale Sida; Coalition Internationale Sida, Pantin, France; Espace Confiance, Abidjan, Côte d'Ivoire; Espace Confiance, Côte d'Ivoire; Espoir Vie Togo, Lomé, Togo; Espoir Vie-Togo - ONG; Expertise France; Institut de Médecine Tropicale, Anvers, Belgique; Laboratoire BIOLIM, Université de Lomé; SESSTIM (IRD, Inserm, Université Aix-Marseille); Université Montpellier